Filtered By:
Condition: Heart Disease
Countries: USA Health
This page shows you your search results in order of relevance. This is page number 18.
Order by Relevance | Date
Total 366 results found since Jan 2013.
Cardiovascular health status of taxi/for-hire vehicle drivers in the United States: A systematic review
CONCLUSIONS: Rigorous and high quality research is needed to further investigate rates of cardiovascular health in this population. The complexity of data collection in this group presents challenges to this endeavor. The high prevalence of poor nutrition, limited physical activity, diabetes, and blood pressure across studies indicates an urgent need to address low rates of health care access at a policy level and to design targeted workplace interventions.PMID:34219688 | DOI:10.3233/WOR-213525
Source: Work - July 5, 2021 Category: Occupational Health Authors: Sheena Mirpuri Kathryn Traub Sara Romero Marisol Hernandez Francesca Gany Source Type: research
Meta-Analysis Addressing the Effect of Mineralcorticoid Receptor Antagonists on the Risk for New-Onset Atrial Fibrillation
Atrial fibrillation (AF) constitutes the most common, major cardiac arrhythmia worldwide, with an estimated prevalence in the United States equal to 2.3 million affected subjects, projected to increase to 5.6 million by 2050.1 Hypertension and background heart disease (mainly, congestive heart failure) or valve disease represent main risk factors for AF development.1 Other modifiable risk factors are sedentary lifestyle, smoking, obesity, diabetes mellitus, and obstructive sleep apnea.2 AF is associated with a significant increase in the risk for all-cause and cardiovascular death, ischemic stroke, heart failure (HF), isch...
Source: The American Journal of Cardiology - August 13, 2021 Category: Cardiology Authors: Dimitrios Patoulias, Christodoulos Papadopoulos, Maria Toumpourleka, Michael Doumas Source Type: research
Trends in Meeting the Aerobic Physical Activity Guideline Among Adults With and Without Select Chronic Health Conditions, United States, 1998-2018
CONCLUSIONS: Although rising trends in physical activity levels among adults with chronic health conditions are encouraging for improving chronic disease management, current prevalence remains low, particularly among older adults. Increasing physical activity should remain a priority for chronic disease management and control.PMID:34465653 | DOI:10.1123/jpah.2021-0178
Source: Journal of Physical Activity and Health - September 1, 2021 Category: Sports Medicine Authors: John D Omura Eric T Hyde Giuseppina Imperatore Fleetwood Loustalot Louise Murphy Mary Puckett Kathleen B Watson Susan A Carlson Source Type: research
Measuring the COVID-19 Mortality Burden in the United States : A Microsimulation Study
CONCLUSION: Beyond excess deaths alone, the COVID-19 pandemic imposed a greater life expectancy burden on persons aged 25 to 64 years, including those with average or above-average life expectancies, and a disproportionate burden on Black and Hispanic communities.PRIMARY FUNDING SOURCE: National Institute on Aging.PMID:34543588 | DOI:10.7326/M21-2239
Source: Annals of Internal Medicine - September 20, 2021 Category: Internal Medicine Authors: Julian Reif Hanke Heun-Johnson Bryan Tysinger Darius Lakdawalla Source Type: research
Fifth Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report
CONCLUSIONS: This Fifth Pedimacs Report demonstrates the continued robust growth of VADs in the pediatric community, now with over 1000 patients reported to the registry. The multiple available device types (PC, PP, IC) serve different populations with different pre-VAD risk profiles, which may account for differences in survival and AE between device types.PMID:34648810 | DOI:10.1016/j.athoracsur.2021.10.001
Source: The Annals of Thoracic Surgery - October 14, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Joseph W Rossano Christina J VanderPluym David M Peng Seth A Hollander Katsuhide Maeda Iki Adachi Ryan R Davies Kathleen E Simpson Francis Fynn-Thompson Jennifer Conway Sabrina P Law Ryan Cantor Devin Koehl Jeffrey P Jacobs Shahnawaz Amdani James K Kirkli Source Type: research
Bringing WISDOM to Breast Cancer Care
Dr. Laura Esserman answers the door of her bright yellow Victorian home in San Francisco’s Ashbury neighborhood with a phone at her ear. She’s wrapping up one of several meetings that day with her research team at University of California, San Francisco, where she heads the Carol Franc Buck Breast Care Center. She motions me in and reseats herself at a makeshift home office desk in her living room, sandwiched between a grand piano and set of enormous windows overlooking her front yard’s flower garden. It’s her remote base of operations when she’s not seeing patients or operating at the hospita...
Source: TIME: Health - October 22, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Source Type: news
Trans Fats On the Way Out? The FDA Moves to Ban Partially Hydrogenated Oils
(HealthCastle.com) You probably know that trans fats are bad for you: They raise your LDL (bad) cholesterol and can increase your risk of heart disease or stroke. Some countries have already banned them. In the United States, trans fats were not even required to be listed on product labels until 2006. Now, just seven years later, the U.S. Food and Drug Administration (FDA) is moving to phase artificial trans fats out from packaged foods sold in the United States.read more
Source: HealthCastle.com Nutrition Tips - written by Registered Dietitians - November 21, 2013 Category: Nutrition Source Type: news
Couple and family interventions for high mortality health conditions: A strategic review (2010 –2019)
AbstractThe earliest publications in the field of marriage and family therapy introduced interventions conducted with families experiencing complex health conditions. This strategic review captures an evaluation of efficacy for 87 couple and family interventions published between 2010 and 2019 with a focus on the leading causes of mortality in the United States. These health conditions include chromosomal anomalies and accidents with infants aged 0 –4 years; accidents and cancer among children aged 5–14; accidents among adolescents aged 15–24; and heart disease, cancer, accidents, chronic lower respiratory diseases,...
Source: Journal of Marital and Family Therapy - November 6, 2021 Category: Psychiatry & Psychology Authors: Angela L. Lamson,
Jennifer L. Hodgson,
Keeley J. Pratt,
Tai J. Mendenhall,
Alison G. Wong,
Erin M. Sesemann,
Braden J. Brown,
Erika S. Taylor,
Jacqueline M. Williams ‐Reade,
Daniel J. Blocker,
Jennifer Harsh Caspari,
Max Zubatsky,
Matthew P. Tags: ORIGINAL ARTICLE Source Type: research
Pharmacotherapy of obesity in complex diseases
SummaryMore than 40% of adults in the United States suffer from obesity. Obesity is inextricably linked to many chronic illnesses like type-2 diabetes mellitus, hypertension, hyperlipidemia, heart disease, sleep apnea, stroke, and cancers. When used in combination with lifestyle modifications, pharmacotherapy has a vital role in treating obesity and improves short-term and long-term outcomes. A growing number of physicians are now interested in obesity medicine, and many of them are seeking guidance on how to treat complex patients with co-morbidities. This review provides a practical guide to the use of anti-obesity medic...
Source: Clinical Obesity - December 13, 2021 Category: Eating Disorders & Weight Management Authors: Vishnu Priya Pulipati,
Silvana Pannain Tags: Review Source Type: research
New ERLEADA ® (apalutamide) Analysis Demonstrates Rapid, Deep Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
SAN FRANCISCO, Feb. 14, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new real-world evidence data showing the initiation of ERLEADA® (apalutamide) results in high rates of rapid and deep prostate-specific antigen (PSA) response among patients with metastatic castration-sensitive prostate cancer (mCSPC). In a separate post-hoc analysis of the registrational Phase 3 SPARTAN and TITAN studies, rapid and deep PSA responses with ERLEADA® were associated with improvement in patient-reported outcomes (PROs) related to quality of life, physical wellbeing, pain, and fatigue intensity. The...
Source: Johnson and Johnson - February 14, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
